Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse
- PMID: 23555752
- PMCID: PMC3608568
- DOI: 10.1371/journal.pone.0059701
Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse
Erratum in
- PLoS One. 2014;9(1). doi:10.1371/annotation/f277b29e-361b-4e56-b55b-612ebaca0432
Abstract
Our ability to successfully intervene in disease processes is dependent on definitive diagnosis. In the case of autoimmune disease, this is particularly challenging because progression of disease is lengthy and multifactorial. Here we show the first chronological compendium of transcriptional and cellular signatures of diabetes in the non-obese diabetic mouse. Our data relates the immunological environment of the islets of Langerhans with the transcriptional profile at discrete times. Based on these data, we have parsed diabetes into several discrete phases. First, there is a type I interferon signature that precedes T cell activation. Second, there is synchronous infiltration of all immunological cellular subsets and a period of control. Finally, there is the killing phase of the diabetogenic process that is correlated with an NF-kB signature. Our data provides a framework for future examination of autoimmune diabetes and its disease progression markers.
Conflict of interest statement
Figures
References
-
- Todd JA (2010) Etiology of type 1 diabetes. Immunity 32: 457–467. - PubMed
-
- Santamaria P (2010) The long and winding road to understanding and conquering type 1 diabetes. Immunity 32: 437–445. - PubMed
-
- Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314: 1360–1368. - PubMed
-
- Wicker LS, Todd JA, Peterson LB (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13: 179–200. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
